SynthesisFrontiers in oncology2026
The multifaceted impact of the COVID-19 pandemic on colorectal cancer care: a systematic review of management disruptions, stage migration, and survival outcomes.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic caused a catastrophic disruption to global healthcare systems. For colorectal cancer (CRC), the world's third most prevalent cancer, the suspension of screening programs and reallocation of resources threatened to severely impact timely diagnosis and treatment, with pre-existing models predicting significant excess mortality from even short delays. Objective: This systematic review aimed to assess the impact of the COVID-19 pandemic on the management strategies, treatment outcomes, and survival rates of patients with colorectal cancer. Methods: A systematic review was conducted following PRISMA guidelines. A comprehensive search of PubMed was performed for studies published from 2020 onwards. Eligible studies included those focusing on adult CRC patients and reporting on changes in care pathways or outcomes due to the pandemic. Data on diagnostic delays, treatment modifications, stage at presentation, and survival were extracted and synthesized narratively. Results: The synthesis of results from the included studies revealed a cascade of negative consequences. There was a severe global reduction in CRC screening, with participation declining by 30-80% and colonoscopy volumes falling by up to 92%, leading to a pool of "missing" diagnoses. This resulted in a significant stage shift, with a higher proportion of patients presenting with advanced stage (e.g., Stage IV) and locally advanced tumors. Treatment protocols were modified, including reduced elective surgical volumes and increased use of neoadjuvant therapy. Consequently, patients diagnosed during the pandemic faced a significantly higher mortality risk, a trend exacerbated by COVID-19 co-infection, which was associated with dramatically worse survival. The pandemic also exacerbated health disparities and imposed a profound psychosocial burden on patients. Conclusion: The COVID-19 pandemic had a detrimental impact on every facet of colorectal cancer care, from screening and diagnosis to treatment and outcomes, leading to more advanced disease at presentation and worsening survival. These findings underscore the critical need to develop resilient cancer care systems that can maintain essential services during future public health crises. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42025638100.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.